# Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy

> **NCT00610103** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** apomorphine hydrochloride

## Key facts

- **NCT ID:** NCT00610103
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610103, "Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00610103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*